News Archive

Faculty and teams from the Duke Clinical Research Institute (DCRI) contributed to a broad range of scientific and educational sessions at the 2026 European Society of Cardiology (ESC) Congress, held Aug. 28-31 in Munich. Their work was featured across presentations, guideline discussions, chair and discussant roles, and several of the congress's highly anticipated Hot Line studies.

The Duke Clinical Research Institute (DCRI) recently welcomed 33 students to the 2026 Summer Training in Academic Research (STAR) Program — the largest cohort since the program’s launched in 2012. STAR is a research training program for high school, undergraduate, and medical students that combines virtual and in-person instruction in research methodology and scientific writing.

The American Heart Association announced the reappointment of Adrian Hernandez, MD, MHS, to its Southeast Board of Directors for the 2026–2027 fiscal year, recognizing his continued leadership and commitment to advancing the organization’s mission.

The Duke Clinical Research Institute (DCRI) Fellowship Program recently entered a new chapter as Daniel Gonzalez, PharmD, PhD, assumed the role of director and Jennifer Rymer, MD, MBA, MHS, became associate director on July 1. The appointments follow six years of leadership from Sana Al-Khatib, MD, MHS, Adam Goode, PhD, DPT, and Neha Pagidipati, MD, MPH, who guided the DCRI’s flagship postdoctoral training program through a period of significant growth and transformation.

Behind every successful Duke Clinical Research Institute (DCRI) study or partnership are the people whose efforts made it possible. On Tuesday, June 30, the DCRI came together virtually as the finale of the organization’s Town Hall to celebrate the fourth annual 2026 DCRI Excellence Awards.

Manesh Patel, MD, officially begins his term as president of the American Heart Association on July 1, stepping into one of the most visi

New findings from a large, real-world study offer reassuring evidence: the Pfizer-BioNTech COVID-19 vaccine continues to demonstrate a strong and consistent safety profile years after individuals received their first vaccine.Recently published in the journal Respiratory Medicine, “Long-term safety of the Pfizer-BioNTech COVID-19 vaccine: Results from the HERO-together study” highlights data and analysis from HERO-Together, a patient-centered research initiative designed to examine potential side effects and hospitalizations reported by participants after receiving a COVID-19 vaccine.

DCRI Accomplishments showcases the publications, awards, and other achievements of our faculty members. Each quarter, a new collection will highlight the most recent accomplishments. During Spring 2026, DCRI faculty members were appointed to leadership roles in influential scientific and medical organizations, and received prestigious awards and notable promotions.

The Duke Clinical Research Institute (DCRI) and CardioVascular Clinical Trialists (CVCT) have announced a formal three-year partnership to establish a clear pathway to regulatory and clinical acceptance of cardiovascular prevention therapies. Titled "Pathway to Prevention," the initiative will unite stakeholders from academia, industry, government, nonprofits, and the technology sector to develop practical guidance to advance prevention indications.

Against the backdrop of two milestone anniversaries, the Duke Clinical Research Institute (DCRI) and Duke Clinical & Translational Science Institute (CTSI) came together to host a research symposium, “Trustworthy Translation – Stories of Today, Visions of Tomorrow,” focused on the practical application of putting evidence into practice to improve health.